Rashid, Fadi – Trademark Portfolio
Entity Type: 01
Rashid, Fadi holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 3 filings in this category. The portfolio also extends into Class 31 (Natural Agricultural Products) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include HEMP AVENUE, HEMP AVENUE SKIN CARE, and H HEMP AVENUE SKIN CARE. The owner is based in Inglewood, CA.
4236 West Imperial Highway
Inglewood, CA 90304
Showing of trademarks Trademarks
Trademark Classifications
Rashid, Fadi's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Rashid, Fadi have?
Rashid, Fadi has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 abandoned.
What trademark classes does Rashid, Fadi file in?
Rashid, Fadi files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 31 (Natural Agricultural Products), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Rashid, Fadi's most well-known trademarks?
Rashid, Fadi's registered trademark portfolio includes well-known marks such as HEMP AVENUE, HEMP AVENUE SKIN CARE, and H HEMP AVENUE SKIN CARE. These are among 3 currently registered trademarks in the portfolio.
What is Rashid, Fadi's trademark registration success rate?
Rashid, Fadi has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.